ACAD

Name: ACAD FDA catalyst calendar
Creator: Pharmaconomics

ACADIA PHARMS INC

3 catalysts on file

ACAD

ACADIA PHARMS INC

Approval Confirmed

Nuplazid

161d ago Apr 27, 2026

openFDA verified 3mo ago

ACAD

Acadia Pharmaceuticals Inc

Phase 2 AI-extracted

remlifanserin

Alzheimer’s disease psychosis

35d ago Aug 31, 2026

SEC 8-K verified 3mo ago

ACAD

Acadia Pharmaceuticals Inc

Phase 2 AI-extracted

trofinetide

Rett syndrome

T-minus 56 days Nov 30, 2026

SEC 8-K verified 3mo ago